PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 62 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $311,000 | -95.5% | 25,000 | -88.8% | 0.00% | -100.0% |
Q3 2021 | $6,950,000 | +870.7% | 222,400 | +789.6% | 0.00% | – |
Q2 2021 | $716,000 | -33.9% | 25,000 | 0.0% | 0.00% | – |
Q1 2021 | $1,083,000 | -24.3% | 25,000 | +25.0% | 0.00% | – |
Q4 2020 | $1,431,000 | +137.3% | 20,000 | 0.0% | 0.00% | – |
Q3 2020 | $603,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $313,740,000 | 3.45% |
Baker Brothers Advisors | 10,123,824 | $316,370,000 | 1.39% |
Logos Global Management LP | 400,000 | $12,500,000 | 0.90% |
HHLR ADVISORS, LTD. | 583,333 | $18,229,000 | 0.24% |
Rock Springs Capital Management LP | 362,359 | $11,324,000 | 0.24% |
Virtus ETF Advisers LLC | 6,292 | $197,000 | 0.09% |
FEDERATED HERMES, INC. | 408,100 | $12,753,000 | 0.02% |
Virtu Financial LLC | 7,940 | $248,000 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS LLC | 1,483,319 | $46,353,719,000 | 0.02% |
FMR LLC | 7,055,666 | $220,489,000 | 0.02% |